<bill session="115" type="h" number="2244" updated="2017-09-28T22:30:14Z">
  <state datetime="2017-04-28">REFERRED</state>
  <status>
    <introduced datetime="2017-04-28"/>
  </status>
  <introduced datetime="2017-04-28"/>
  <titles>
    <title type="short" as="introduced">Patient Experience in Research Act of 2017</title>
    <title type="short" as="introduced">Patient Experience in Research Act of 2017</title>
    <title type="official" as="introduced">To direct the Secretary of Health and Human Services to carry out a pilot project under which no more than 3 sponsors agree to evaluate the psychological and social distress experienced by patients participating in a clinical trial, conducted by the respective sponsor, of a drug or biological product that is intended to treat a serious or life-threatening disease or condition, and for other purposes.</title>
    <title type="display">Patient Experience in Research Act of 2017</title>
  </titles>
  <sponsor bioguide_id="L000567"/>
  <cosponsors>
    <cosponsor bioguide_id="C001067" joined="2017-05-22"/>
    <cosponsor bioguide_id="D000197" joined="2017-04-28"/>
    <cosponsor bioguide_id="E000215" joined="2017-05-22"/>
  </cosponsors>
  <actions>
    <action datetime="2017-04-28">
      <text>Introduced in House</text>
    </action>
    <action datetime="2017-04-28" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2017-05-05">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Medical research"/>
    <term name="Mental health"/>
    <term name="User charges and fees"/>
  </subjects>
  <amendments/>
  <summary date="2017-04-28T04:00:00Z" status="Introduced in House">Patient Experience in Research Act of 2017

This bill requires the Food and Drug Administration to carry out a pilot project under which sponsors of new drugs or biological products agree to evaluate: (1) the distress experienced by patients in clinical trials for medications intended to treat a serious condition, and (2) the effects of providing support to distressed patients on the outcome of a clinical trial. The user fee is waived for new drug applications that include data from such an evaluation.</summary>
  <committee-reports/>
</bill>
